title: Is sustained release natrexone an option for heroin-dependent pregnant women?
authors: Norwegian Center for Addiction Research, Oslo University, PO Box 1171, Blindern, 0318, Oslo. helge.waal@medisin.uio.no
authors: Helge
authors: H
authors: Waal
mesh_terms: D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D009271:Naltrexone / Q000008:administration & dosage* / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D058850:Opiate Substitution Treatment / Q000379:methods; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D051381:Rats; D012107:Research Design
chemical_list: D009292:Narcotic Antagonists; D009271:Naltrexone